Monthly Archives: October 2021

                        
                            

Corneal Cross-Linking Treatment Remains Generally Stable 10-years Post Treatment

             
Corneal Cross-Linking Treatment Remains Generally Stable 10-years Post Treatment
               
                   

Epi-off corneal collagen cross-linking (CXL) treatment treats progressive keratoconus and ectasia that develops after refractive surgery. The procedure received FDA approval in 2016. Dr. Greenstein and his colleagues conducted a study to determine how well the procedure faired over the years. The study concluded that the treatment appears to remain stable for the majority of […]

Read More                
               
           
                               
request a free consultation
request appointment
contact us